Concepedia

Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost–utility analysis

N.L. Liberato, Carla Rognoni, Stefania Rubrichi, Silvana Quaglini, Monia Marchetti, Thierry Gorlia, Lisa Licitra, Jan B. Vermorken

Annals of Oncology · 2011 · 26 citations · 20 references

DOI

Concepts

References

20

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Jean‐Pierre Pignon, Aurélie Le Maître, E. Maillard et al. · Radiotherapy and Oncology · 2009 · 3K citations

, , +8

An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

David J. Adelstein, Yi Li, George L. Adams et al. · Journal of Clinical Oncology · 2002 · 1.7K citations

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

A convenient approximation of life expectancy (the “DEALE”)

J. Robert Beck, Stephen G. Pauker, Jonathan E. Gottlieb et al. · The American Journal of Medicine · 1982 · 476 citations

, , +4